Investment Rating - The investment rating for the company is "Buy" and is maintained [9]. Core Insights - In 2025, the company achieved a revenue of 3.603 billion yuan, representing a year-on-year increase of 12.4%. The net profit attributable to the parent company was 425 million yuan, up 20.6% year-on-year, while the net profit excluding non-recurring items was 385 million yuan, an increase of 20.8% year-on-year [2][6]. - The company continues to focus on strategic emerging industries such as military, automotive, and new energy, which are maintaining good growth momentum. The rapid development of aerospace and integrated circuits, along with the growth of innovative capabilities in data science and new materials testing, is also notable [2][6]. Revenue Summary - The company’s revenue growth rates for each quarter in 2025 were 5.2%, 13.8%, 14.9%, and 13.4% respectively. The revenue for Q4 was 1.187 billion yuan, a year-on-year increase of 13.4% [13]. - Revenue by business segment includes: - Measurement services: 757 million yuan, up 1.6% - Reliability and environmental testing: 893 million yuan, up 14.6% - Integrated circuit testing: 309 million yuan, up 21.0% - Electromagnetic compatibility testing: 423 million yuan, up 16.8% - Data science analysis and evaluation: 272 million yuan, up 126.4% - Life sciences: 472 million yuan, down 5.3% - EHS evaluation services: 133 million yuan, down 26.6% [13]. Profit Summary - The company’s net profit margin for 2025 was 12.3%, an increase of approximately 1.1 percentage points year-on-year. The gross profit margin was 46.8%, a slight decrease of about 0.37 percentage points [13]. - The company implemented refined management practices, leading to a significant reduction in impairment losses, which decreased from 107 million yuan in the previous year to 17 million yuan in 2025 [13]. Cash Flow and Dividends - The company reported a net operating cash flow of 952 million yuan in 2025, an increase of 11.3% year-on-year, with Q4 alone contributing 694 million yuan, a year-on-year increase of approximately 33.9% [13]. - Total cash dividends and buybacks in 2025 amounted to approximately 207 million yuan, representing 48.75% of the net profit attributable to the parent company [13]. Future Outlook - The company completed a targeted issuance of shares, raising approximately 1.292 billion yuan, which will be invested in various strategic projects, including testing platforms for aerospace equipment and artificial intelligence chips [13]. - Revenue forecasts for 2026-2028 are projected at 4.11 billion yuan, 4.699 billion yuan, and 5.309 billion yuan, with corresponding net profits of 537 million yuan, 664 million yuan, and 805 million yuan, indicating growth rates of 26.6%, 23.5%, and 21.3% respectively [13].

Group 1 - The Sichuan Zhenxing Science and Technology Innovation Equity Investment Fund Partnership has completed its registration with a total scale of 5.055 billion yuan [1] - The fund is established with contributions from Sichuan Social Security Science and Technology Innovation Equity Investment Fund, Sichuan Juxin Zhiyuan Private Fund Management Co., Ltd., and CCB Investment Private Fund Management (Beijing) Co., Ltd. [1] - The fund will focus on investment areas including new energy, new materials, biomedicine, artificial intelligence, robotics, integrated circuits, and digital economy [1] Group 2 - The fund aims to create a virtuous cycle of technology-driven growth, industry acceleration, and stable value appreciation [1]

Core Viewpoint - Muxi Co., Ltd. (沐曦股份) is strategically enhancing its capabilities in the high-performance GPU sector by establishing subsidiaries in Shanghai, focusing on a comprehensive strategy that integrates chip design, software development, and ecosystem building [1][5][6]. Group 1: Company Developments - On January 20, 2026, Muxi Digital (Shanghai) Technology Co., Ltd. was established with a registered capital of 100 million RMB, focusing on integrated circuit design and sales, marking a significant step in the company's hardware business in Shanghai [1]. - On March 19, 2026, Muxi New Intelligence Technology (Shanghai) Co., Ltd. was founded with a registered capital of 50 million RMB, extending the company's reach into AI software and algorithm development, thus enhancing its strategic depth [3][4]. - The establishment of Muxi New Intelligence is seen as a move to strengthen the synergy between foundational computing chips and upper-layer AI applications, transitioning towards an integrated solution of chips and algorithm optimization [4]. Group 2: Strategic Positioning - Muxi Co., Ltd. has been deeply involved in full-stack GPU product research and design since its inception in 2020, and its recent establishment of subsidiaries reflects a concentrated effort to build a national collaborative innovation network [5]. - The company aims to leverage Shanghai's advantages in the integrated circuit industry and AI development to solidify its hardware research foundation while capturing technological advancements in AI theory and algorithms [5][6]. - Muxi New Intelligence is expected to become a key base for innovation at the intersection of AI foundational theory and chip design, enhancing the company's core products and contributing to the evolution of domestic general-purpose computing capabilities [5][6].

Investment Rating - The report maintains a "Buy" rating for the company [6][4]. Core Insights - The company achieved a revenue of 2.248 billion yuan in 2025, representing a year-on-year increase of 10.97%. The net profit attributable to shareholders reached 257 million yuan, up 12.22% year-on-year [1]. - In Q4 2025, the company reported a revenue of 716 million yuan, a year-on-year increase of 15.54% and a quarter-on-quarter increase of 32.30%. The net profit attributable to shareholders for the same quarter was 101 million yuan, reflecting a year-on-year growth of 21.18% and a quarter-on-quarter growth of 154.36% [2]. - The aerospace sector generated 426 million yuan in revenue for the year, marking a significant year-on-year growth of 43.20% with a gross margin of 51.75% [3]. - The integrated circuit segment saw a revenue increase of 23.72% year-on-year, driven by technological advancements and increased demand for testing services [3]. Summary by Relevant Sections Financial Performance - In 2025, the company reported total revenue of 2.248 billion yuan, with a net profit of 257 million yuan and a non-recurring net profit of 246 million yuan, showing growth rates of 10.97%, 12.22%, and 18.60% respectively [1]. - The sales gross margin and net margin for 2025 were 41.76% and 12.63%, down 2.78 percentage points and 0.77 percentage points year-on-year [2]. Business Segments - The company’s revenue from testing equipment, environmental reliability testing services, and integrated circuit verification and analysis services in 2025 were 674 million yuan, 1.106 billion yuan, and 357 million yuan respectively, with year-on-year growth rates of 8.28%, 9.57%, and 23.72% [2]. - The aerospace sector is identified as a key growth area, with the company expanding its testing equipment and services to meet the needs of aerospace clients [3]. Profitability and Valuation - The report forecasts a decline in net profit predictions for 2026 and 2027 by 18% and 20% to 311 million yuan and 370 million yuan respectively, while introducing a new forecast for 2028 at 453 million yuan [4]. - The estimated earnings per share (EPS) for 2026, 2027, and 2028 are projected to be 0.61 yuan, 0.73 yuan, and 0.89 yuan respectively [4].

Core Insights - The article highlights significant developments in the investment landscape, particularly focusing on the establishment and funding of various investment funds across different regions in China, indicating a trend towards increased capital flow into innovative sectors. Group 1: Fund Establishments and Investments - Shenzhen's angel investment fund has relaxed return investment constraints, removing local registration requirements for fund managers, marking a pioneering move in the venture capital industry for 2026 [3] - Blue Pool Capital has successfully raised $1 billion (approximately 70 billion RMB), marking the largest dollar fundraising in China this year [4] - A new 100 billion RMB fund, the National Investment and Innovation Fund, has been established in Shanghai, backed by social security funds and major banks, signaling a strong commitment to supporting innovation [6] - The Shanghai Integrated Circuit Industry Private Equity Fund has been launched with an initial scale of 57.02 million RMB, representing a significant step in the city's merger and acquisition strategy [7] - Singapore's Fenglong Xinghe Private Limited has injected 500 million RMB into Shanghai's technology innovation center, focusing on key industries such as integrated circuits and artificial intelligence [9] - Two low-altitude industry funds in Shenzhen have been established, totaling over 1.3 billion RMB, aimed at boosting the low-altitude economy [10] - Chengdu has set up a talent fund with a target scale of 1 billion RMB, focusing on supporting technology talent and quality projects [11] - The Zhongguancun Science City Technology Growth Fund and the Achievement Transformation Fund have completed registration, with a total scale of 10 billion RMB, aimed at supporting strategic emerging industries [12] - The Guangdong Intelligent Robot Fund has been registered with a total scale of 10 billion RMB, focusing on AI and advanced manufacturing [14] - The Shanghai Pudong Smart Manufacturing Phase II Fund has been established with a target scale of 1 billion RMB, focusing on enhancing the local industrial chain [15] - The Shanghai Jiao Yin Guo Xin Fund has been set up with an initial scale of 1 billion RMB, aimed at supporting Shanghai's technology innovation center [16] - The Hubei New Chu Seed Fund has completed registration with a total scale of 500 million RMB, focusing on seed investments in technology projects [19] Group 2: Policy Developments and Strategic Initiatives - Guangdong Province has introduced a new policy to support artificial intelligence OPC innovation development, marking a significant step in promoting new entrepreneurial models [40] - The Beijing-Tianjin-Hebei Venture Capital Guidance Fund has completed its first batch of key project agreements, with a total scale of 1 billion RMB, focusing on early-stage investments in strategic emerging industries [25] - The Hainan Free Trade Port Construction Investment Fund is set to invest in two GP funds, with a total scale of 1.2 billion RMB for one fund and 400 million RMB for another, aimed at supporting innovation in the region [27]

Investment Rating - The investment rating for the company is "Accumulate" [5] Core Views - The company's performance in 2025 met expectations, with total revenue of 2.25 billion yuan, a year-on-year increase of 11%, and a net profit attributable to shareholders of 256 million yuan, up 12% year-on-year, aligning with market forecasts [2] - The integrated circuit segment is a key driver of growth, with revenue expected to reach 360 million yuan in 2025, reflecting a 24% year-on-year increase due to the release of laboratory capacity [2] - The aerospace sector is also a significant growth engine, with projected revenue of approximately 430 million yuan in 2025, representing a 43% increase [4] Financial Performance Summary - In 2025, the company's gross profit margin was 41.8%, a decrease of 2.8 percentage points year-on-year, while the net profit margin was 12.6%, down 0.8 percentage points [3] - The company’s operating expenses ratio was 26.5%, a decrease of 2.4 percentage points year-on-year, indicating improved cost efficiency [3] - The forecast for net profit attributable to shareholders for 2026-2028 is 320 million, 390 million, and 480 million yuan respectively, with corresponding P/E ratios of 26, 21, and 17 [5]

Core Viewpoint - Jieli Technology is expected to experience growth in the first quarter of 2026 after a period of consolidation in 2025, as indicated in their prospectus [1]. Financial Performance - Estimated revenue for Q1 2026 is projected to be between 67,000 and 73,000 thousand yuan, representing a year-on-year increase of 14.24% to 24.47% compared to 58,648.68 thousand yuan in Q1 2025 [2]. - Net profit attributable to the parent company is expected to be between 14,600 and 15,600 thousand yuan, reflecting a growth of 7.22% to 14.56% from 13,617.41 thousand yuan in the same period last year [2]. - The net profit after deducting non-recurring gains and losses is projected to be between 13,300 and 14,300 thousand yuan, indicating a rise of 12.16% to 20.60% from 11,857.71 thousand yuan in Q1 2025 [2]. Technological Innovation - Jieli Technology focuses on system-on-chip (SoC) design and has established a strong technological foundation with 370 authorized invention patents, 64 integrated circuit layout designs, and 188 software copyrights as of June 30, 2025 [2]. - The company has developed core technologies in architecture design, low power consumption, RF, and audio, with notable performance metrics such as a TWS Bluetooth headset chip playback power consumption of less than 4.0mA and a Bluetooth RF with 35ms ultra-low latency [2]. Research and Development - The R&D team consists of 353 personnel, accounting for 70.46% of the total workforce, with many having over ten years of experience in SoC design [3]. - Cumulative R&D investment reached 882 million yuan, enabling the company to respond quickly to market demands and launch 2-4 popular product series annually [3]. Market Position and Product Range - Jieli Technology's products are known for high specifications, flexibility, and integration, covering various categories such as Bluetooth headset chips, Bluetooth speaker chips, smart wearable chips, and IoT terminal chips [3]. - The company sold 5.266 billion Bluetooth audio chips from 2022 to 2024, surpassing the total sales of five other listed companies in the same industry during the same period, indicating a strong market position [3]. Strategic Development - The growth in Q1 2026 is attributed to continuous efforts in product structure optimization and market expansion, with increasing sales of mid-to-high-end Bluetooth headset chips and steady growth in emerging fields like smart wearables and IoT [4]. - Jieli Technology has established partnerships with major brands such as Xiaomi, Realme, Honor, and VIVO, enhancing its market recognition through stable product performance and quality technical services [4]. Industry Collaboration - The company has formed stable cooperative relationships with upstream and downstream enterprises in the industry chain, including major wafer foundries and packaging testing companies, enhancing key technical indicators to industry-leading levels [6]. - Jieli Technology aims to become a platform-type chip design enterprise by focusing on core areas such as Bluetooth audio and video, smart wearables, and AIoT edge computing chip development, promoting high-quality development in the integrated circuit industry [6].

Economic Growth Goals - The economic growth target for 2026 is set at an elastic range of 4.5% to 5%, with an emphasis on achieving better results in practice [1] - This target aligns with the long-term goal of achieving basic socialist modernization by 2035 and allows for necessary space to adjust structures and mitigate risks [1] - The focus is on improving resource allocation efficiency and achieving qualitative improvements alongside reasonable quantitative growth [1] Consumer Price and Domestic Market - The expected increase in consumer prices is set at around 2%, aiming for a moderate recovery in overall price levels [2] - The report emphasizes the importance of leveraging China's large domestic market to expand new spaces for domestic demand growth [2] - Strategies include enhancing residents' consumption capacity and willingness through income plans, social security improvements, and optimizing consumer credit environments [2] Investment Focus - The investment strategy will concentrate on new productive forces, new urbanization, and comprehensive human development [3] - There will be increased investment in technological upgrades, industrial upgrades, and major technological infrastructure through long-term special government bonds and new policy financial tools [3] - The aim is to foster new momentum and develop a modern industrial system while supporting traditional industries with significant equipment updates [3] Macroeconomic Policies - The report highlights the integration of stock and incremental policies to enhance counter-cyclical and cross-cyclical adjustments for stable growth [4] - The fiscal policy aims for a deficit rate of around 4%, with an increase in the deficit scale by 230 billion yuan, and a public budget expenditure reaching 30 trillion yuan [4] - The focus is on optimizing expenditure structures to support consumption, investment in people, and ensuring livelihoods [4] Monetary Policy - The core consideration for monetary policy is to promote stable economic growth and reasonable price recovery [5] - The policy will focus on actual interest rates and inflation expectations, utilizing various tools like reserve requirement ratio cuts and interest rate reductions to maintain ample liquidity [5] - New policy financial tools worth 800 billion yuan will be issued to guide financial institutions in supporting key areas such as domestic demand expansion, technological innovation, and small and medium enterprises [5]

Investment Rating - The report maintains an "Overweight" rating for the industry [6] Core Insights - The pharmaceutical sector is experiencing volatility and differentiation, with structural opportunities arising from policy catalysts and performance windows. The Shanghai Composite Index fell by 1.07%, while the pharmaceutical sector dropped by 2.78%, ranking 17th among 31 sub-industries. Notably, the market showed a rebound after initial geopolitical concerns, driven by positive mentions of pharmaceuticals in the government work report [8][14] - The report emphasizes the importance of the upcoming Q1 earnings reports, which are expected to provide positive catalysts, particularly for companies like Ailis, which anticipates a 41% revenue increase and a 44% rise in net profit [8][14] - The government work report highlights the development of emerging industries, including biomedicine, and reiterates the focus on innovative drugs and medical devices. This marks the third consecutive year that "innovative drugs" have been included in the report, indicating a sustained commitment to this sector [8][14] Summary by Sections Market Dynamics - The pharmaceutical sector's performance is influenced by both policy changes and market conditions, with a notable decline in various sub-sectors such as medical services and traditional Chinese medicine [8][14] - The report indicates that the pharmaceutical sector's valuation is currently at 22.4 times PE based on 2026 earnings forecasts, which is a premium of 8.4% compared to the overall A-share market [23] Investment Recommendations - The report suggests focusing on three main investment lines: 1. Leading biotech and biopharma companies that are expected to benefit from improved payment environments and global competitiveness, such as Kangfang Biotech and BeiGene [8][14] 2. Upstream and CXO sectors supported by "patient capital," with companies like WuXi Biologics and Tigermed highlighted as potential beneficiaries [8][14] 3. Cutting-edge fields such as brain-computer interfaces and AI in healthcare, with specific companies recommended for investment [8][14] Company Performance - The report notes that companies in the innovative drug sector have shown strong performance, particularly those with ongoing product developments. Conversely, stocks that previously experienced significant gains are now facing corrections [29]

Domestic Developments - The Ministry of Science and Technology issued guidelines for the development of a comprehensive technology insurance system, aiming to support high-level technological self-reliance and innovation through 20 measures[9] - The National Development and Reform Commission held a meeting focusing on expanding domestic demand and stabilizing investment, with a commitment to accelerate targeted policies for private enterprises[10] - A tax data report indicated that by 2025, over 80% of provinces in China will see positive growth in inter-provincial sales, reflecting the progress in building a unified national market[12] International Developments - The U.S. and Israel launched strikes against Iran, leading to significant geopolitical tensions and fluctuations in asset prices, including a rise in oil prices above $80 per barrel[16] - In February, the U.S. manufacturing PMI remained in expansion territory at 52.4, but the input price index surged to a near four-year high of 70.5, indicating rising inflationary pressures[18] - The Eurozone's February CPI rose by 1.9% year-on-year, exceeding expectations, driven by increased service prices, particularly in Italy, which saw a 6.1% rise in restaurant and accommodation costs[21] Market Trends - Brent crude oil prices increased by 15.77% week-on-week, while iron ore prices rose by 0.72%, indicating upward pressure in commodity markets[25] - Real estate sales surged by 63.37% week-on-week, reflecting a strong recovery in the housing market[25] - The DXI index for storage DRAM prices increased by 2.15% week-on-week, suggesting a positive trend in emerging industries[33]